Introduction

Athersys reports benefits of their MultiStem® stem cell therapy in acute spinal cord injury

Athersys reports benefits of their MultiStem® stem cell therapy in acute spinal cord injury

In a preclinical rodent model of SCI, researchers observed that a non-invasive intravenous administration of MultiStem cells one day after injury results in accelerated recovery, significant improvements in locomotor function and fine motor tests, and significant improvement in bladder function.

Said Robert Mays, Ph.D., Head of Neuroscience at Athersys. “These results suggest that an off-the-shelf cell therapy, such as MultiStem, administered intravenously shortly after the injury, may have the potential to provide substantial and meaningful benefits to patients.”

Read more…